Most drugs used today have only one mechanism of action and it is both difficult and expensive to manufacture drugs with multiple functions. Researchers at the NNF-funded research center, CEMBID, at Aarhus University have recently found a way to create more stable nanostructures that can assemble biomolecules with different functions, which in combination e.g., can provide more effective cancer medicine.